News | October 09, 2024
Jubilant Ingrevia becomes only Indian company to join WEF’s Global Lighthouse Network
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Strategic focus on COCO-model with a nationwide reach of 501 stores
CSPC will receive an upfront payment of $100 million from AstraZeneca
Poor oral health (periodontal disease) impacts nearly 51% of Indians
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Subscribe To Our Newsletter & Stay Updated
